SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as the FDA moves to block compounded versions of popular GLP-1 weight-loss drugs, a significant catalyst that strengthens the brand dominance of official products like Wegovy and Ozempic. The community is actively discussing this regulatory shift, with many investors anticipating that the reduced competition will accelerate adoption, boost market share, and act as a tailwind heading into the upcoming earnings report.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing significant momentum and retail interest as investors connect the company's specialized MRAM technology to broader AI memory and aerospace growth narratives. Market participants are actively debating the sustainability of this rapid move, with bulls pointing to recent defense contracts and low float as catalysts for a potential squeeze, while some skeptics express concerns over high valuations and technical resistance.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and speculative momentum as investors rotate back into Japanese blockchain projects and IoT-focused assets. While community sentiment remains polarized between long-term holders citing ecosystem expansion and skeptics highlighting a lack of official partnership news, traders are closely monitoring technical breakouts and exchange accumulation trends.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are actively debating the future of CRO, with community sentiment split between frustration over persistent token dilution and optimism regarding potential ETF filings and mobile app developments. While some participants are aggressively accumulating, others remain wary, highlighting concerns over management transparency and historical underperformance relative to broader market gains.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending following a corporate update regarding financial results and the company's progress toward a pivotal Phase 3 clinical trial for its lead candidate, CAD-1005, aimed at treating heparin-induced thrombocytopenia. While some community members are optimistic about the upcoming trial registration path and orphan drug designations, others are expressing skepticism, focusing on potential share dilution and concerns over aggressive social media promotion.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF (SNDQ) is seeing significant volume and trader attention as market participants attempt to hedge against the rapid, parabolic price appreciation in SanDisk (SNDK). The community is actively debating the sustainability of the semiconductor sector's momentum, with many users employing SNDQ as a tactical vehicle to bet on a potential correction or reversal.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is trending as community members aggressively debate its long-term potential as a high-speed institutional settlement layer, often citing its reported partnership history and infrastructure capabilities. The discussion is heavily polarized between bullish investors highlighting its 11M TPS architecture and potential fintech use cases versus skeptics who dismiss the activity as repetitive spam or an unproven pump-and-dump scheme.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is currently facing significant volatility as investors weigh strong quarterly revenue and earnings beats against concerns over lowered forward guidance and broader fears that AI agents could disrupt the traditional SaaS business model. The community remains deeply divided, with some investors aggressively buying the dip due to the company's strong cash position and growth metrics, while others warn of potential further downside fueled by intense short-selling pressure and skepticism regarding long-term software viability in an AI-native market.

AIOZ Network is a DePIN for Web3 AI, Storage and Streaming.  AIOZ empowers a faster, secure and decentralized future.   Powered by a global network of DePINs,  AIOZ rewards you for sharing your computational resources for storing, transcoding, and streaming digital media content and powering decentralized AI computation.

AIOZ Network

AIOZ Network is trending as investors highlight its DePIN utility and AI-focused infrastructure, with the community closely tracking its relative strength compared to other altcoins during market volatility. Many are actively discussing its potential for a breakout, citing historical price patterns and upcoming industry conferences as catalysts for a potential return to higher valuations.

LPKF Laser & Electronics SE engages in the provision of laser-based solutions for the technology industry. It operates through the following segments: Electronics, Development, Welding, and Solar. The Electronics segment refers to the production systems for cutting print stencils, circuit boards, thin glass, and the etching of plastic circuit carriers. The Development segment includes circuit board plotters and ProtoLasers, primarily for electronics developers. The Welding segment comprises systems for laser beam welding of plastic components. The Solar segment develops and produces laser scribers for the etching of thin-film solar cells and laser systems for the digital printing of functional pastes and inks. The company was founded by Jurgen Seebach, Klaus Barke, Klaus Sülter, and Bernd Hildebrandt in 1976 and is headquartered in Garbsen, Germany.

LPKF Laser & Electronics SE

LPKFF is trending as investors gain conviction in its laser-based glass substrate technology, which is seen as a critical component for future AI chip packaging and optics. The community is actively discussing the stock's potential for a significant re-rating as they anticipate increased demand from major semiconductor partnerships and a ramp-up in next-generation manufacturing infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMD If it touches the $125 area tomorrow, might be a short term bottom. Almost oversold across the board here. This $125-127 area is very important support. If broken, it might get ugly.

FundamentalValues

Wade

PunishedTrump

Asiya

Lane Dickson

StockTwits Web

Kyle Vallans

Advanced Micro Devices Inc

 If it touches the $125 area tomorrow, might be a short term bottom. Almost oversold across the board here. This $125-127 area is very important support. If broken, it might get ugly.

Bradley

@bradley_b Correcting.  It is already ugly so it could get uglier for sure 125 and then 120 next supports.

 Correcting.  It is already ugly so it could get uglier for sure 125 and then 120 next supports.

Roger

@seazest 20% already since ER. Big correction since since early this year, down 50% here.

 20% already since ER. Big correction since since early this year, down 50% here.

@bradley_b @seazest y&#39;all gotta be nuts worrying about buying here

What gift. 

Scale in easy as that

StockTwits For Android 

 y'all gotta be nuts worrying about buying here

What gift. 

Scale in easy as that